VANCERIL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Vanceril, and what generic alternatives are available?
Vanceril is a drug marketed by Schering and is included in two NDAs.
The generic ingredient in VANCERIL is beclomethasone dipropionate. There are twenty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the beclomethasone dipropionate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for VANCERIL?
- What are the global sales for VANCERIL?
- What is Average Wholesale Price for VANCERIL?
Summary for VANCERIL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 65 |
Clinical Trials: | 1 |
Patent Applications: | 4,892 |
DailyMed Link: | VANCERIL at DailyMed |
Recent Clinical Trials for VANCERIL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Fred Hutchinson Cancer Research Center | Phase 2 |
US Patents and Regulatory Information for VANCERIL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Schering | VANCERIL | beclomethasone dipropionate | AEROSOL, METERED;INHALATION | 017573-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Schering | VANCERIL DOUBLE STRENGTH | beclomethasone dipropionate | AEROSOL, METERED;INHALATION | 020486-001 | Dec 24, 1996 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for VANCERIL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Schering | VANCERIL | beclomethasone dipropionate | AEROSOL, METERED;INHALATION | 017573-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Schering | VANCERIL | beclomethasone dipropionate | AEROSOL, METERED;INHALATION | 017573-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Schering | VANCERIL | beclomethasone dipropionate | AEROSOL, METERED;INHALATION | 017573-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for VANCERIL
See the table below for patents covering VANCERIL around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
South Africa | 7302713 | ⤷ Sign Up | |
Luxembourg | 67462 | ⤷ Sign Up | |
Japan | S531814 | ⤷ Sign Up | |
Japan | S4919014 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |